APA (7th ed.) Citation

Tsai, M., Lin, Y., Chen, D., Lin, M., Wang, C., Hsieh, I., . . . Chen, T. (2024). Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention. Clinical pharmacology and therapeutics, 116(3), 747-756. https://doi.org/10.1002/cpt.3209

Chicago Style (17th ed.) Citation

Tsai, Ming‐Lung, Yuan Lin, Dong‐Yi Chen, Ming‐Shyan Lin, Chao‐Yung Wang, I‐Chang Hsieh, Ning‐I Yang, Ming‐Jui Hung, and Tien‐Hsing Chen. "Ticagrelor Versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics 116, no. 3 (2024): 747-756. https://doi.org/10.1002/cpt.3209.

MLA (9th ed.) Citation

Tsai, Ming‐Lung, et al. "Ticagrelor Versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics, vol. 116, no. 3, 2024, pp. 747-756, https://doi.org/10.1002/cpt.3209.